REDWOOD CITY, Calif., May 04, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus“, Nasdaq:CHRS) today announced that senior management will participate in the following investor conferences:
- Bank of America Merrill Lynch Global Healthcare 2023 Conference in Las Vegas on Thursday, May 11, 2023; fireside chat at 10:15 a.m. PDT
- UBS Global Healthcare Conference at UBS NY headquarters on Tuesday, May 23, 2023 for 1×1 meetings only between 8:00 a.m. and 5:00 p.m. EDT
An audio webcast of the fireside chat presentation will be available on the investors’ page of the Coherus website at http://investors.coherus.com. Please access the website prior to the start of the presentation to ensure a timely connection to the webcast. The webcast will be archived on the Coherus website for 30 days.
Coherus Contact Information:
Marek Ciszewski, SVP Investor Relations
IR@coherus.com
Related news for (CHRS)
- Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update
- Coherus Divesting UDENYCA Franchise to Intas Pharmaceuticals for up to $558M
- Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
- Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in $170 Million Upfront All Cash Deal
- Coherus Presents Positive Phase 2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2024 ASCO GI Cancers Symposium